BB1 3.85% 27.0¢ blinklab limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6

  1. 3,584 Posts.
    lightbulb Created with Sketch. 187
    As far as I have seen and in the latest roadshow, Brian said the technology works, now they are preparing for FDA approval this half.

    I am not concerned with the D&O insurance cost. If this stock flys in near term which I personally expect it to be, who cares about the D&O insurance. I am sure there would be reason why the premium paid.

    I suggest you get on board soon before the train leaves




 
watchlist Created with Sketch. Add BB1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.